Coronary Artery Restenosis Unknown Status Phase 3 Trials for Everolimus (DB01590)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00426049Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent ImplantationTreatment